Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer

Detalles Bibliográficos
Autores principales: Xu, Jiahui, Liu, Deying, Niu, Huilin, Zhu, Guifang, Xu, Yangwei, Ye, Danli, Li, Jian, Zhang, Qingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843975/
https://www.ncbi.nlm.nih.gov/pubmed/36647144
http://dx.doi.org/10.1186/s13046-023-02593-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843975/
https://www.ncbi.nlm.nih.gov/pubmed/36647144
http://dx.doi.org/10.1186/s13046-023-02593-5

Ejemplares similares